354 related articles for article (PubMed ID: 20032432)
21. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
22. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
[TBL] [Abstract][Full Text] [Related]
23. Association of surgery with improved survival in stage IV breast cancer patients.
Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
[TBL] [Abstract][Full Text] [Related]
24. Gastric tumor from metastasis of breast cancer.
Yamamoto D; Yoshida H; Sumida K; Ueyama Y; Kanematsu S; Shoji T; Sueoka N; Tanaka K; Tsubota Y; Kon M
Anticancer Res; 2010 Sep; 30(9):3705-8. PubMed ID: 20944157
[TBL] [Abstract][Full Text] [Related]
25. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
26. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
27. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
[TBL] [Abstract][Full Text] [Related]
28. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
29. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
30. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
Carter MR; Hornick JL; Lester S; Fletcher CD
Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
[TBL] [Abstract][Full Text] [Related]
31. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma metastatic to the stomach: single-centre experience and literature review.
Pollheimer MJ; Hinterleitner TA; Pollheimer VS; Schlemmer A; Langner C
BJU Int; 2008 Aug; 102(3):315-9. PubMed ID: 18336607
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
35. [Critical analysis of the long-term management of a case of cancer of the breast].
D'Amato A; Pezzoli F; Balducci G; Bocchetti T; Ziparo V
Chir Ital; 2006; 58(3):377-81. PubMed ID: 16845877
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for patients with liver metastases from breast cancer.
Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
[TBL] [Abstract][Full Text] [Related]
37. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
38. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
Vincent-Salomon A; Jouve M; Genin P; Fréneaux P; Sigal-Zafrani B; Caly M; Beuzeboc P; Pouillart P; Sastre-Garau X
Cancer; 2002 Apr; 94(8):2169-73. PubMed ID: 12001113
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal metastases from breast cancer: report of two cases.
Gerova VA; Tankova LT; Mihova AA; Drandarska IL; Kadian HO
Hepatogastroenterology; 2012; 59(113):178-81. PubMed ID: 22251535
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]